10 diseases tracked
Where the research stands
For each incurable disease: what is being tested, which phase each treatment is in and what changed recently. Data from official clinical trial registries, scientific papers and company announcements, reviewed before publishing.
Autoimmune diseases 5
Celiac Disease
9 candidates tracked
furthest alongPhase 2 complete
FB102 clears phase 2, heads to phase 3
Lupus
8 candidates tracked
furthest alongPhase 3
Dapirolizumab cuts flares at EULAR
Multiple Sclerosis
6 candidates tracked
furthest alongFiled for approval
Nasal foralumab reduces microglial activation in progressive MS
Crohn's and Ulcerative Colitis
4 candidates tracked
furthest alongPhase 3 complete
Obefazimod nears its approval filing
Type 1 Diabetes
4 candidates tracked
furthest alongPhase 3
Edited cells last 14 months without immunosuppression
Neurological diseases 3
Other diseases 2
Latest updates
ProgressNasal foralumab reduces microglial activation in progressive MS
ProgressFB102 clears phase 2, heads to phase 3
ProgressFDA accepts fenebrutinib filing
ProgressFDA approves tavapadon (Juvmo)
ProgressUlefnersen works in FUS-ALS
ProgressTEV-53408 prevents gut damage
ProgressReview flags the acute phase as a treatment window
StoppedTakeda drops TAK-101
How to read the meter
- 1/5Lab / pilot: early research
- 2/5Phase 1: safety
- 3/5Phase 2: efficacy and dose
- 4/5Phase 3: confirmation
- 5/5Filed for approval: agency review